Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	11.69B -21.1%
Revenue (ttm)	4.17B -2.6%
Net Income	960.76M -14.5%
EPS	11.20 -15.3%
Shares Out	84.72M
PE Ratio	12.32
Forward PE	10.10
Dividend	7.75 (5.62%)
Ex-Dividend Date	Mar 26, 2026

Volume	1,040,554
Open	131.00
Previous Close	130.50
Day's Range	131.00 - 138.50
52-Week Range	122.00 - 219.50
Beta	0.32
Analysts	Hold
Price Target	150.00 (+8.7%)
Earnings Date	Aug 11, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical instruments, eyeglasses, contact lenses, and eyeglass accessories. It is also involved in eyeglasses optometry and dispensing services and leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy analysis, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses f...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2025, TPEX:3218's revenue was 4.20 billion, a decrease of -0.57% compared to the previous year's 4.23 billion. Earnings were 1.04 billion, a decrease of -2.07%.